Cholesterol drug shows promise for cancer Survivors' swallowing woes

This study tests whether a common cholesterol medication, pravastatin, can improve swallowing difficulties caused by past radiation treatment for head and neck cancer. Researchers will give 48 participants pravastatin daily for 12 months and monitor changes in swallowing function. The goal is to see if this drug can reduce scarring and ease a long-term side effect that affects many survivors.